# Trade Mark Journal No.2026/005 30 January 2026

## WO0000001896612 (1,5)

Office of origin: United States of America

Date of International Registration:28 August 2025
Date of designation in the UK: 28 August 2025

Three broken concentric circles, the inner circle having a dot located between its breaking point, the middle circle having a dot located between each of its two breaking points, and the outer circle having a dot located between one of its three breaking points.

International priority date claimed: 28 February 2025 (United States of America) (99061738)

Class 1
  Biochemical preparations for scientific purposes; chemical and biochemical products in the nature of chemical preparations for scientific use and for research, other than for medical or veterinary use; chemical and biochemical products in the nature of chemical preparations for scientific use and for research in the field of genetics, for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and production of transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and pseudo-viral particles, other than for medical or veterinary use; chemical and biochemical test kits for scientific laboratory use and for research use containing chemical preparations, agents and reagents, for life science research, virus, protein, antibody production and in vivo injection; chemical and biochemical test kits for scientific laboratory use and for research use containing chemical preparations, agents and reagents in the field of genetics, for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and production of transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and pseudo-viral particles; chemical preparations for scientific purposes; chemical preparations, agents and reagents for scientific use and for scientific research for genetic diagnosis; chemical reagents for non-medical purposes.
Class 5
  Chemicals and biochemicals for medical and clinical use, namely, chemical and biochemical preparations for discovery and development of cell and gene therapy for treating genetic diseases; chemicals and biochemicals for medical and clinical use in the field of genetics, namely, chemical and biochemical preparations for transferring biological molecules into living cells, integrating foreign nucleic acids into the genome of living cells and producing transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and pseudo-virus particles for the discovery and development of cell and gene therapies for treating genetic diseases; chemical preparations for medical use, namely, for the discovery, development and delivery of cell and gene therapies for treating genetic diseases; diagnostic agents for medical use; reagents for medical use; chemical and biochemical diagnostic reagent test kits for medical and clinical use comprised of medical diagnostic preparations, agents and reagents for use in disease testing; diagnostic assay kits and chemical and biochemical diagnostic test kits, all for medical and clinical use in the field of genetics, comprised of preparations, agents and reagents for transferring biological molecules into living cells, integrating foreign nucleic acids into the genome of living cells and producing transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and pseudo-virus particles, for use in disease testing; pharmaceutical products for the treatment of genetic diseases; medicines for the treatment of genetic diseases.

Kyfora Bio, LLC

Representative: David M. Tener Caesar Rivise, PC, 7 Penn Center, 12th Floor, 1635 Market Street, Philadelphia PA 19103, UNITED STATES OF AMERICA